Cowen Inc’s Zimmer Biomet ZBH Stock Holding History

Cowen Inc’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,150	Closed	-$642K	–	326
2017 Q2	$642K	Buy	+5,150	New	+$611K	0.03%	202

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Cowen Inc's ZBH Position: Q1 2018 in Review

Cowen Inc sold out of Zimmer Biomet (ZBH) in Q1 2018, closing a stake of 4,635 shares — an estimated $543K sold.

Cowen Inc first reported a position in ZBH in Q2 2017 and held it in 2 quarters. The position peaked at $543K in Q4 2017. 876 funds tracked by Wall St. Rank hold ZBH as of Q1 2018.

Cowen Inc reported no remaining Zimmer Biomet position as of Q1 2018 after selling out during the quarter.
Cowen Inc sold 4,635 Zimmer Biomet shares in Q1 2018, an estimated $543K.
Cowen Inc first reported a position in Zimmer Biomet in Q2 2017 and held it in 2 quarters.
Cowen Inc's Zimmer Biomet position peaked at $543K in Q4 2017.
876 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2018.

Based on Cowen Inc's 13F filing for Q1 2018, filed 15 May 2018.